πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 13 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12312345

Fluoroalkyl-oxadiazoles and uses thereof

Tenaya Therapeutics, Inc. Β· Granted Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12201617

HDAC6 inhibitors for treatment of metabolic disease and HFpEF

Tenaya Therapeutics, Inc. Β· Granted Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12168778

Cardiac cell reprogramming with myocardin and ASCL1

Tenaya Therapeutics, Inc. Β· Granted Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12151001

Optimized expression cassettes for gene therapy

Tenaya Therapeutics, Inc. Β· Granted Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12104165

Adeno-associated virus with engineered capsid

Tenaya Therapeutics, Inc. Β· Granted Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11926622

Fluoroalkyl-oxadiazoles and uses thereof

Tenaya Therapeutics, Inc. Β· Granted Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11913012

Cardiac cell reprogramming with myocardin and ASCL1

Tenaya Therapeutics, Inc. Β· Granted Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11781156

Plakophillin-2 gene therapy methods and compositions

Tenaya Therapeutics, Inc. Β· Granted Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11759531

Gene therapy vectors for treating heart disease

Tenaya Therapeutics, Inc. Β· Granted Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11578066

Fluoroalkyl-oxadiazoles and uses thereof

Tenaya Therapeutics, Inc. Β· Granted Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11446397

Gene therapy vectors for treating heart disease

Tenaya Therapeutics, Inc. Β· Granted Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11129908

Gene therapy vectors for treating heart disease

Tenaya Therapeutics, Inc. Β· Granted Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11015211

Cardiac cell reprogramming with myocardin and ASCL1

Tenaya Therapeutics, Inc. Β· Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted